Related Experiment Video
Updated: Apr 15, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Summary and future directions
1Departments of Pathology & Lymphoid Cancer Research, Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC Canada.
Abstract:
Our understanding of disease biology and treatment paradigms in diffuse large B-cell lymphoma (DLBCL) is now sufficiently mature that we are poised to enter a new phase of hematological oncology. To achieve the goal of precision medicine and begin to logically deploy the vast array of currently available, novel targeted therapies we must develop a roadmap for clinical research. We urgently need robust biomarkers to inform the results of current and planned randomized, controlled phase III clinical trials. These biomarkers should capitalize on our current understanding of the genetic landscape of DLBCL and will help to define those patients destined to fail R-CHOP. But more importantly, they will inform the molecular correlates of treatment failure for planned clinical trials testing novel agents and combinations. If successful, we can move the field past the vast array of prognostic markers and develop predictive biomarkers that direct future therapy.
More Related Videos
07:50Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
09:52Measuring and Manipulating Functionally Specific Neural Pathways in the Human Motor System with Transcranial Magnetic Stimulation
Published on: February 23, 2020
Related Concept Videos
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Sanger Sequencing
Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Human Virome
Microorganisms in Medicine and Therapeutics